Gut microbiome: New biomarkers in early screening of colorectal cancer
- PMID: 35312122
- PMCID: PMC9102648
- DOI: 10.1002/jcla.24359
Gut microbiome: New biomarkers in early screening of colorectal cancer
Abstract
Background: Certain "star intestinal bacteria" have been found to act as a contributor to the development of colorectal cancer (CRC). Besides, given that the gut microbiome can be detected in a diverse range of samples (stool, tissue, blood, etc), it is categorized into fecal microbiome, blood microbiome, and tissue microbiome.
Methods: To provide an overview of the recent research progress, this review summarizes the characteristics of the gut microbiome in different samples at each stage of CRC and their screening efficiency.
Results: The screening models constructed from different sample microbiomes (healthy/colorectal adenoma, healthy/CRC, and colorectal adenoma/CRC) have both strengths and constraints in terms of biomarker reproducibility and area under the receiver-operating characteristic curve (AUC) of the screening models. Many bacteria, such as Bifidobacteria, Fusobacterium nucleatum (F. n), Geotrichum candidum, Porphyromonas asaccharolytica, Escherichia coli, Rhodococcus, Anaerostipes caccae, Enhydrobacter, Lachnoclostridiumsp. m3, Bacteroides clarus, Clostridium hathewayi, Ruminococcaceae, Bacteroides thetaiotaomicron, Culinariside, and enterotoxigenic Bacteroides fragilis (ETBF), show favorable diagnostic efficacy in early screening of colorectal cancer.
Conclusions: This review highlights stool, blood, tissue, and bowel fluid are the main sample sources for biomarkers, each with its own advantages and limitations. Moreover, other samples such as extracellular vesicles and biofilms also should been deserved further attention.
Keywords: biomarker; colorectal cancer; diagnosis; gut microbiome; progress.
© 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209‐249. - PubMed
-
- Wu CX, Gu K, Gong YM, et al. Analysis of incidence and mortality of colorectal cancer in China. China Oncology. 2020;30(04):241‐245.
-
- Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490‐1502. - PubMed
-
- Lu M, Chen HD, Liu CC, et al. Diagnostic performance of quantitative fecal immunochemical test in detection of advanced colorectal neoplasia. Chin J Epidemiol. 2020;41(12):2104‐2111. - PubMed
-
- Zhang MC, Ge ZX, Yuan SJ, et al. Colorectal cancer and intestinal microbiota. Chin J Microecol. 2019;31(9):1097‐1099+1104.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical